v3.21.1
Earnings Per Share (Tables)
3 Months Ended
Mar. 31, 2021
Earnings Per Share [Abstract]  
Schedule of basic and diluted earnings per share, impact of two-class method The following table summarizes the impact of the two-class method:
Three months ended
March 31,
(in millions, except per share data)20212020
Basic EPS
Net earnings attributable to AbbVie Inc.$3,553 $3,010 
Earnings allocated to participating securities24 14 
Earnings available to common shareholders$3,529 $2,996 
Weighted-average basic shares outstanding1,769 1,481 
Basic earnings per share attributable to AbbVie Inc.$2.00 $2.02 
Diluted EPS
Net earnings attributable to AbbVie Inc.$3,553 $3,010 
Earnings allocated to participating securities24 14 
Earnings available to common shareholders$3,529 $2,996 
Weighted-average shares of common stock outstanding1,769 1,481 
Effect of dilutive securities
Weighted-average diluted shares outstanding1,775 1,484 
Diluted earnings per share attributable to AbbVie Inc.$1.99 $2.02